Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor L Carlson

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|November 9, 2017
Mucus models to evaluate the diffusion of drugs and particlesJaclyn Y Lock, Taylor L Carlson, Rebecca L Carrier
Macromolecular Bioscience|February 4, 2015
Mucus Barriers to Microparticles and Microbes are Altered in Hirschsprung's DiseaseHasan M Yildiz, Taylor L Carlson, Allan M Goldstein, et al.
Plos One|December 22, 2018
Lipids alter microbial transport through intestinal mucusTaylor L Carlson, Hasan Yildiz, Zaineb Dar, et al.
Scientific Reports|July 4, 2018
Acute Exposure to Commonly Ingested Emulsifiers Alters Intestinal Mucus Structure and Transport PropertiesJaclyn Y Lock, Taylor L Carlson, Chia-Ming Wang, et al.
Scientific Reports|April 23, 2020
Impact of Developmental Age, Necrotizing Enterocolitis Associated Stress, and Oral Therapeutic Intervention on Mucus Barrier PropertiesJaclyn Y Lock, Taylor L Carlson, Yueyue Yu, et al.
Molecular Metabolism|November 21, 2025
Additive effects of GLY-200 (oral pharmacologic duodenal exclusion therapy) and GLP-1R agonist in obesity managementTaylor L Carlson, Mark Fineman, Stace Kernodle, et al.
SLAS Technology|November 30, 2017
Emulation of Colonic Oxygen Gradients in a MicrodeviceDavid I Walsh, E Victoria Dydek, Jaclyn Y Lock, et al.
Science Advances|May 30, 2025
Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseasesTaylor L Carlson, Kevin Colbert, Marcela Vieira, et al.
Nature Communications|August 15, 2025
BMI1 regulates human erythroid self-renewal through both gene repression and gene activationKathleen E McGrath, Jayme L Olsen, Anne D Koniski, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|November 9, 2017
Mucus models to evaluate the diffusion of drugs and particlesJaclyn Y Lock, Taylor L Carlson, Rebecca L Carrier
Macromolecular Bioscience|February 4, 2015
Mucus Barriers to Microparticles and Microbes are Altered in Hirschsprung's DiseaseHasan M Yildiz, Taylor L Carlson, Allan M Goldstein, et al.
Plos One|December 22, 2018
Lipids alter microbial transport through intestinal mucusTaylor L Carlson, Hasan Yildiz, Zaineb Dar, et al.
Scientific Reports|July 4, 2018
Acute Exposure to Commonly Ingested Emulsifiers Alters Intestinal Mucus Structure and Transport PropertiesJaclyn Y Lock, Taylor L Carlson, Chia-Ming Wang, et al.
Scientific Reports|April 23, 2020
Impact of Developmental Age, Necrotizing Enterocolitis Associated Stress, and Oral Therapeutic Intervention on Mucus Barrier PropertiesJaclyn Y Lock, Taylor L Carlson, Yueyue Yu, et al.
Molecular Metabolism|November 21, 2025
Additive effects of GLY-200 (oral pharmacologic duodenal exclusion therapy) and GLP-1R agonist in obesity managementTaylor L Carlson, Mark Fineman, Stace Kernodle, et al.
SLAS Technology|November 30, 2017
Emulation of Colonic Oxygen Gradients in a MicrodeviceDavid I Walsh, E Victoria Dydek, Jaclyn Y Lock, et al.
Science Advances|May 30, 2025
Development of a targeted oral pharmacologic duodenal exclusion therapy for the treatment of metabolic diseasesTaylor L Carlson, Kevin Colbert, Marcela Vieira, et al.
Nature Communications|August 15, 2025
BMI1 regulates human erythroid self-renewal through both gene repression and gene activationKathleen E McGrath, Jayme L Olsen, Anne D Koniski, et al.
Pageof 1